際際滷

際際滷Share a Scribd company logo
Is Cytisine at least as effective as NRT for smoking
cessation?
 BACKGROUND
 Cytisine is a plant-based Alkaloid found in members of the Leguminosae
family,a partial agonist that binds the nicotinic acetylcholine receptors
(nAChRs)
 Cytisine is used for smoking cessation,it has been available both with and
without prescription for smoking cessation since 1960s largely in Eastern
Europe
 Cytisine is a generic agent currently manufactured by Sopharma as Tabex
and Aflofarm Pharma as Desmoxan
 4 Systematic reviews report Cytisine to be superior to
placebo for short-term and long-term abstinence and
almost doubles the chances of quiting at 6 months
 Given that no trials have compared Cytisine with
Nicotine Replacement Therapy(NRT),we designed a
non-inferiority trial to investigate wether Cytisine was at
least as effective as NRT
 METHODS
 1310 -(655 per group) adult smokers were randomly assigned in a1:1
ratio to receive Cytisine for 25 days or NRT for 8 weeks
 Participants-Inclusion criteria
 Smokers motivated to qiut(were recruited through the New Zealand Quitline
 To be at lesast 18 of age
 Dayli smokers
 Able to provide verbal consent
 Have access to telephone
 Participants-Exclusion criteria
 Pregnant/Breastfeeding
 Non-dayli smokers
 Current users of NRT products
 Currently enrolled in another smoking cessation study
 Heart attack,uncontrolled high blood pressure, schizophrenia
 TREATMENT ALLOCATION
 INTERVENTION GROUP
25 days course of Cytisine(1.5
mg per tablet)
 Days 1-3 : 1 tablet/2 hrs
through the day
 Days 4-12 : 1 tablet/2.5 hrs;
DESIGNED QD is day5
 Days 13-16 : 1 tablet/3 hrs
 Days 17-20 : 1 tablet/4-5 hrs
 Days 21-25 : 1 tablet/6 hrs
 USUAL CARE GROUP
8 weeks NRT :
 Nicotine Patches :7,14 or 21 mg
and/or gum: 2 mg or 4 mg
or lozenge: 1 mg or 2 mg
 Type and strenght of NRT were
determinated by Quitline
advisors
 TREATMENT REGIME
 CYTISINE/TABEX
Days 1-3 : 1.5 mg/2 hours
Days 4-12 :1.5 mg /2.5 hours
DESIGNED QIUT DAY- DAY 5
Days 13-16 : 1.5 mg/3 hours
Days 17-20 : 1.5 mg/4-5 hours
Days 21 -25 : 1.5 mg/6 hours
 VARENICLINE/CHAMPIX
Days 1-3 : 0.5 mg once daily
Days 4-7 : 0.5 mg twice daily
DESIGNED QUIT DAY- DAY 7-14
Day 8 to week 12 :n1n mg twice daily
 BASELINE CHARACTERISTIC OF THE PARTICIPANTS
CHARACTERISTICS CYTISINE
N=655
NRT
N=655
FEMALE SEX-no(%) 372(57%) 372(57%)
AGE(yrs) 37.8 38.4
CIGARETTES SMOKED PER DAY 19.3 19.0
CIGARETTE DEPENDENCE 5.4 5.3
AGE STARTED SMOKING(yrs) 15.2 15.5
 OUTCOMES
 Primary outcomes
 continuous abstinence since quit day
 Secondary outcomes - assessed at 1 week and 1,2, and 6 months(after
quit day)
 total number of Cytisine tablets taken or the type,strenght and amount of
NRT
 7-Day piont preavalance for abstinence(no cigarettes,not a single puff in the
previous 7 days)
Tabex 2
Tabex 2
Tabex 2
Tabex 2

More Related Content

Tabex 2

  • 1. Is Cytisine at least as effective as NRT for smoking cessation?
  • 2. BACKGROUND Cytisine is a plant-based Alkaloid found in members of the Leguminosae family,a partial agonist that binds the nicotinic acetylcholine receptors (nAChRs) Cytisine is used for smoking cessation,it has been available both with and without prescription for smoking cessation since 1960s largely in Eastern Europe Cytisine is a generic agent currently manufactured by Sopharma as Tabex and Aflofarm Pharma as Desmoxan
  • 3. 4 Systematic reviews report Cytisine to be superior to placebo for short-term and long-term abstinence and almost doubles the chances of quiting at 6 months Given that no trials have compared Cytisine with Nicotine Replacement Therapy(NRT),we designed a non-inferiority trial to investigate wether Cytisine was at least as effective as NRT
  • 4. METHODS 1310 -(655 per group) adult smokers were randomly assigned in a1:1 ratio to receive Cytisine for 25 days or NRT for 8 weeks Participants-Inclusion criteria Smokers motivated to qiut(were recruited through the New Zealand Quitline To be at lesast 18 of age Dayli smokers Able to provide verbal consent Have access to telephone Participants-Exclusion criteria Pregnant/Breastfeeding Non-dayli smokers Current users of NRT products Currently enrolled in another smoking cessation study Heart attack,uncontrolled high blood pressure, schizophrenia
  • 5. TREATMENT ALLOCATION INTERVENTION GROUP 25 days course of Cytisine(1.5 mg per tablet) Days 1-3 : 1 tablet/2 hrs through the day Days 4-12 : 1 tablet/2.5 hrs; DESIGNED QD is day5 Days 13-16 : 1 tablet/3 hrs Days 17-20 : 1 tablet/4-5 hrs Days 21-25 : 1 tablet/6 hrs USUAL CARE GROUP 8 weeks NRT : Nicotine Patches :7,14 or 21 mg and/or gum: 2 mg or 4 mg or lozenge: 1 mg or 2 mg Type and strenght of NRT were determinated by Quitline advisors
  • 6. TREATMENT REGIME CYTISINE/TABEX Days 1-3 : 1.5 mg/2 hours Days 4-12 :1.5 mg /2.5 hours DESIGNED QIUT DAY- DAY 5 Days 13-16 : 1.5 mg/3 hours Days 17-20 : 1.5 mg/4-5 hours Days 21 -25 : 1.5 mg/6 hours VARENICLINE/CHAMPIX Days 1-3 : 0.5 mg once daily Days 4-7 : 0.5 mg twice daily DESIGNED QUIT DAY- DAY 7-14 Day 8 to week 12 :n1n mg twice daily
  • 7. BASELINE CHARACTERISTIC OF THE PARTICIPANTS CHARACTERISTICS CYTISINE N=655 NRT N=655 FEMALE SEX-no(%) 372(57%) 372(57%) AGE(yrs) 37.8 38.4 CIGARETTES SMOKED PER DAY 19.3 19.0 CIGARETTE DEPENDENCE 5.4 5.3 AGE STARTED SMOKING(yrs) 15.2 15.5
  • 8. OUTCOMES Primary outcomes continuous abstinence since quit day Secondary outcomes - assessed at 1 week and 1,2, and 6 months(after quit day) total number of Cytisine tablets taken or the type,strenght and amount of NRT 7-Day piont preavalance for abstinence(no cigarettes,not a single puff in the previous 7 days)